LENALIDOMIDE
lenalidomide 15 mg capsule, 21
LENALIDOMIDE (12986L)
12986L
Manner of administration:Oral
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Triple combination therapy consisting of elotuzumab, lenalidomide and dexamethasone
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 2 | DPMQ: $340.45 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||